Aligned Genetics Inc (238120) — Cash Flow Quality Index
Aligned Genetics Inc (238120) has a Cash Flow Quality Index of -2.19x as of September 2025. Operating cash flow of ₩-2.04 Billion is below net income of ₩933.05 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore long-term investment intensity of Aligned Genetics Inc to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Aligned Genetics Inc Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Aligned Genetics Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Aligned Genetics Inc to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Aligned Genetics Inc (2019–2024)
Year-by-year earnings quality comparison for Aligned Genetics Inc. For live market cap and the full company financial profile, see market value of Aligned Genetics Inc.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.74x | ₩3.07 Billion | ₩4.13 Billion | ▼ -15.6% |
| 2023 | 0.88x | ₩2.85 Billion | ₩3.24 Billion | ▼ -7.6% |
| 2022 | 0.95x | ₩2.22 Billion | ₩2.33 Billion | ▲ +3782.9% |
| 2021 | 0.02x | ₩135.97 Million | ₩5.54 Billion | ▼ -67.8% |
| 2020 | 0.08x | ₩35.67 Million | ₩468.23 Million | ▼ -98.7% |
| 2019 | 5.65x | ₩659.29 Million | ₩116.74 Million | — |